Integrin Beta-3 Gene Polymorphism and Risk for Myocardial Infarction in Premature Coronary Disease
Open Access
- 1 June 2019
- journal article
- research article
- Published by Armenian Green Publishing Co. in Iranian Journal of Biotechnology
- Vol. 17 (2), 79-88
- https://doi.org/10.21859/ijb.1921
Abstract
Background: Contradictory results have been obtained regarding the role of integrin, beta 3 (ITGB3) gene polymorphisms in occurrence of myocardial infarction (MI). Objectives: We aimed to assess the association between 1565C/T polymorphism of ITGB3 gene and increased risk for acute MI in patients with premature coronary artery disease (CAD). Material and Methods: Our study included 1000 premature CAD patients that classified into two groups with history of MI (n = 461) and without of MI (n = 539). The polymorphism variants in 10% of samples were determined by PCR-RFLP technique and genotyping of the polymorphism in all subjects was conducted by High Resolution Melting method. Given the two conditions of patients residing in Tehran and also faced with their first episode of MI, 640 out of 1000 study samples that had been previously followed-up were assessed in a retrospective cohort phase regarding long-term major adverse cardiac events (MACE). Results: There was no significant difference in the frequency of 1565C/T polymorphism between the MI and non-MI groups. The frequency of wild genotype was 69.2% and 72.2%, the frequency of homozygous genotype was 21.3% and 18.4%, and the frequency of mutant genotype was 9.5% and 9.5%, respectively (P = 0.505). No significant difference was also found in total-MACE free survival rate between the patients with different genotypes of 1565C/T polymorphism in both MI and non-MI group. Conclusions: The carriage of the 1565C/T polymorphism of ITGB3 gene seems unlikely to be a significant risk factor for the development of MI in Iranian patients with premature CAD.Keywords
This publication has 28 references indexed in Scilit:
- Standards of Medical Care in Diabetes—2013Diabetes Care, 2012
- The genetics of coronary artery diseaseCurrent Opinion in Cardiology, 2012
- Evolving role of platelet function testing in coronary artery interventionsVascular Health and Risk Management, 2012
- Oral antiplatelet therapy for atherothrombotic disease: overview of current and emerging treatment optionsVascular Health and Risk Management, 2012
- Platelet glycoprotein IIIa (platelet antigen 1/platelet antigen 2) polymorphism and 1-year outcome in patients with stable coronary artery diseaseBlood Coagulation & Fibrinolysis, 2010
- Standards of Medical Care in Diabetes—2010Diabetes Care, 2010
- Effect of glycoprotein IIIa PlA2 polymorphism on outcome of patients with stable coronary artery disease and effect of smokingThe American Journal of Cardiology, 2004
- The platelet polymorphism PlA2 is a genetic risk factor for myocardial infarctionJournal of Internal Medicine, 2004
- Genetic Susceptibility to Death from Coronary Heart Disease in a Study of TwinsThe New England Journal of Medicine, 1994
- Genetic--epidemiologic study of early-onset ischemic heart disease.Circulation, 1980